| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 20 | 2023 | 480 | 3.910 |
Why?
|
| Cartilage, Articular | 33 | 2024 | 1104 | 3.830 |
Why?
|
| Scoliosis | 22 | 2024 | 793 | 2.650 |
Why?
|
| Femur | 20 | 2024 | 1321 | 2.530 |
Why?
|
| Glycosaminoglycans | 18 | 2021 | 611 | 1.910 |
Why?
|
| Hip Dislocation | 5 | 2020 | 249 | 1.480 |
Why?
|
| Bone Density | 27 | 2024 | 3573 | 1.420 |
Why?
|
| Tomography, X-Ray Computed | 51 | 2024 | 20741 | 1.380 |
Why?
|
| Fractures, Spontaneous | 4 | 2016 | 232 | 1.330 |
Why?
|
| Spinal Fusion | 14 | 2022 | 1307 | 1.250 |
Why?
|
| Contrast Media | 26 | 2024 | 5329 | 1.230 |
Why?
|
| X-Ray Microtomography | 15 | 2024 | 456 | 1.130 |
Why?
|
| Tensile Strength | 5 | 2011 | 332 | 1.110 |
Why?
|
| Osteotomy | 4 | 2016 | 837 | 1.100 |
Why?
|
| Thoracoplasty | 3 | 2018 | 15 | 1.090 |
Why?
|
| Compressive Strength | 10 | 2019 | 159 | 1.090 |
Why?
|
| Spine | 11 | 2022 | 1139 | 1.050 |
Why?
|
| Osteoarthritis | 12 | 2024 | 1072 | 0.980 |
Why?
|
| Osteolysis | 5 | 2024 | 274 | 0.900 |
Why?
|
| Ioxaglic Acid | 6 | 2017 | 29 | 0.890 |
Why?
|
| Elastic Modulus | 7 | 2019 | 210 | 0.890 |
Why?
|
| Orthopedic Procedures | 7 | 2023 | 1279 | 0.850 |
Why?
|
| Finite Element Analysis | 5 | 2024 | 441 | 0.810 |
Why?
|
| Fracture Healing | 4 | 2023 | 448 | 0.780 |
Why?
|
| Bone Diseases, Metabolic | 7 | 2023 | 411 | 0.770 |
Why?
|
| Metacarpophalangeal Joint | 3 | 2019 | 82 | 0.750 |
Why?
|
| Bone and Bones | 18 | 2024 | 2587 | 0.690 |
Why?
|
| Absorptiometry, Photon | 12 | 2024 | 1757 | 0.670 |
Why?
|
| Bone Neoplasms | 4 | 2024 | 2563 | 0.660 |
Why?
|
| Progeria | 6 | 2020 | 188 | 0.660 |
Why?
|
| Tibia | 7 | 2016 | 1075 | 0.650 |
Why?
|
| Cervical Vertebrae | 4 | 2020 | 978 | 0.650 |
Why?
|
| Ribs | 6 | 2024 | 257 | 0.590 |
Why?
|
| Osteoporosis | 9 | 2024 | 1604 | 0.580 |
Why?
|
| Growth Plate | 5 | 2024 | 276 | 0.560 |
Why?
|
| Menisci, Tibial | 2 | 2017 | 267 | 0.560 |
Why?
|
| Stress, Mechanical | 13 | 2021 | 1673 | 0.560 |
Why?
|
| Biopolymers | 1 | 2018 | 182 | 0.550 |
Why?
|
| Respiratory Insufficiency | 3 | 2020 | 1240 | 0.550 |
Why?
|
| Models, Animal | 6 | 2021 | 2121 | 0.550 |
Why?
|
| Polymers | 6 | 2023 | 1624 | 0.550 |
Why?
|
| Hip Joint | 4 | 2019 | 1017 | 0.540 |
Why?
|
| Cost of Illness | 2 | 2017 | 1951 | 0.530 |
Why?
|
| Fractures, Bone | 6 | 2015 | 2062 | 0.530 |
Why?
|
| Bone Remodeling | 3 | 2016 | 582 | 0.530 |
Why?
|
| Femoral Neoplasms | 1 | 2016 | 85 | 0.510 |
Why?
|
| Thoracic Vertebrae | 4 | 2018 | 613 | 0.500 |
Why?
|
| Metacarpal Bones | 2 | 2018 | 77 | 0.500 |
Why?
|
| Immobilization | 1 | 2016 | 229 | 0.500 |
Why?
|
| Cattle | 14 | 2021 | 3813 | 0.490 |
Why?
|
| Financing, Personal | 1 | 2017 | 310 | 0.480 |
Why?
|
| Iothalamic Acid | 1 | 2014 | 18 | 0.470 |
Why?
|
| Movement | 2 | 2019 | 1473 | 0.470 |
Why?
|
| Whales | 3 | 2009 | 30 | 0.460 |
Why?
|
| Quality of Life | 7 | 2024 | 13485 | 0.460 |
Why?
|
| Spinal Diseases | 4 | 2020 | 561 | 0.460 |
Why?
|
| Lung | 6 | 2018 | 10076 | 0.450 |
Why?
|
| Acetabulum | 2 | 2020 | 543 | 0.430 |
Why?
|
| Kyphosis | 2 | 2021 | 252 | 0.430 |
Why?
|
| Horses | 10 | 2024 | 294 | 0.430 |
Why?
|
| Rabbits | 11 | 2018 | 4751 | 0.420 |
Why?
|
| Patella | 2 | 2014 | 317 | 0.420 |
Why?
|
| Mobility Limitation | 2 | 2018 | 409 | 0.400 |
Why?
|
| Child | 55 | 2024 | 80771 | 0.400 |
Why?
|
| Caregivers | 4 | 2023 | 2302 | 0.390 |
Why?
|
| Tantalum | 3 | 2023 | 54 | 0.380 |
Why?
|
| Physical Stimulation | 3 | 2016 | 514 | 0.380 |
Why?
|
| Animals | 65 | 2024 | 168965 | 0.360 |
Why?
|
| Nanotechnology | 3 | 2020 | 702 | 0.360 |
Why?
|
| Neuromuscular Diseases | 3 | 2024 | 260 | 0.350 |
Why?
|
| Chondrocytes | 6 | 2022 | 799 | 0.350 |
Why?
|
| Cadaver | 6 | 2019 | 1362 | 0.350 |
Why?
|
| Braces | 2 | 2005 | 139 | 0.350 |
Why?
|
| Disabled Children | 3 | 2017 | 250 | 0.350 |
Why?
|
| Oxides | 3 | 2023 | 402 | 0.340 |
Why?
|
| Syringomyelia | 2 | 2021 | 66 | 0.340 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2024 | 8108 | 0.340 |
Why?
|
| Hip | 3 | 2020 | 256 | 0.330 |
Why?
|
| Female | 91 | 2024 | 396660 | 0.320 |
Why?
|
| Adolescent | 42 | 2024 | 89046 | 0.320 |
Why?
|
| Disability Evaluation | 4 | 2018 | 1829 | 0.310 |
Why?
|
| Orthopedics | 1 | 2017 | 906 | 0.310 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2021 | 159 | 0.310 |
Why?
|
| Fractures, Ununited | 1 | 2010 | 176 | 0.310 |
Why?
|
| Bone Development | 3 | 2021 | 473 | 0.300 |
Why?
|
| Tissue Preservation | 1 | 2008 | 170 | 0.300 |
Why?
|
| Fracture Fixation | 5 | 2012 | 370 | 0.290 |
Why?
|
| Humans | 127 | 2024 | 767040 | 0.280 |
Why?
|
| Femoral Fractures | 2 | 2013 | 376 | 0.280 |
Why?
|
| Lubricants | 2 | 2020 | 26 | 0.280 |
Why?
|
| Rotation | 4 | 2016 | 515 | 0.280 |
Why?
|
| Gadolinium | 2 | 2015 | 964 | 0.280 |
Why?
|
| Male | 76 | 2024 | 364203 | 0.280 |
Why?
|
| Iodobenzenes | 2 | 2017 | 22 | 0.280 |
Why?
|
| Ovariectomy | 5 | 2024 | 612 | 0.270 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 1547 | 0.270 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2022 | 260 | 0.270 |
Why?
|
| Ethylenediamines | 2 | 2017 | 57 | 0.270 |
Why?
|
| Child, Preschool | 27 | 2024 | 42606 | 0.270 |
Why?
|
| Rats | 14 | 2024 | 23713 | 0.270 |
Why?
|
| Osteoarthritis, Knee | 3 | 2020 | 1251 | 0.260 |
Why?
|
| Polyenes | 2 | 2018 | 68 | 0.260 |
Why?
|
| Ultrasonography | 1 | 2019 | 6000 | 0.260 |
Why?
|
| Weight-Bearing | 4 | 2016 | 532 | 0.260 |
Why?
|
| Humeral Fractures | 3 | 2018 | 283 | 0.250 |
Why?
|
| Models, Biological | 6 | 2024 | 9464 | 0.250 |
Why?
|
| Subtraction Technique | 1 | 2008 | 515 | 0.250 |
Why?
|
| Phantoms, Imaging | 6 | 2024 | 2487 | 0.250 |
Why?
|
| Lubrication | 3 | 2023 | 22 | 0.250 |
Why?
|
| Dendrimers | 2 | 2020 | 72 | 0.250 |
Why?
|
| Radiography | 13 | 2024 | 6975 | 0.240 |
Why?
|
| Cartilage Diseases | 1 | 2006 | 160 | 0.240 |
Why?
|
| Titanium | 3 | 2015 | 494 | 0.240 |
Why?
|
| Viscosupplementation | 1 | 2024 | 2 | 0.240 |
Why?
|
| Furans | 2 | 2018 | 199 | 0.240 |
Why?
|
| Health Expenditures | 1 | 2017 | 2390 | 0.230 |
Why?
|
| Cations | 7 | 2024 | 239 | 0.230 |
Why?
|
| Prosthesis Failure | 2 | 2009 | 1208 | 0.220 |
Why?
|
| Specimen Handling | 1 | 2008 | 706 | 0.220 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14672 | 0.220 |
Why?
|
| Povidone-Iodine | 2 | 2020 | 56 | 0.220 |
Why?
|
| Prospective Studies | 19 | 2024 | 54886 | 0.220 |
Why?
|
| Viscosupplements | 2 | 2024 | 19 | 0.210 |
Why?
|
| Phosphorylcholine | 1 | 2023 | 152 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2024 | 36582 | 0.210 |
Why?
|
| Respiratory Function Tests | 3 | 2018 | 1695 | 0.210 |
Why?
|
| Bone Nails | 3 | 2012 | 221 | 0.210 |
Why?
|
| Parents | 2 | 2023 | 3594 | 0.210 |
Why?
|
| Bone Screws | 4 | 2020 | 533 | 0.210 |
Why?
|
| Equipment Failure Analysis | 3 | 2009 | 832 | 0.200 |
Why?
|
| Nanoparticles | 3 | 2024 | 1966 | 0.200 |
Why?
|
| Postoperative Care | 3 | 2024 | 1480 | 0.200 |
Why?
|
| Lamin Type A | 2 | 2020 | 187 | 0.200 |
Why?
|
| Lumbar Vertebrae | 5 | 2022 | 1885 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2017 | 3464 | 0.200 |
Why?
|
| Femur Head | 2 | 2019 | 297 | 0.190 |
Why?
|
| Anorexia Nervosa | 2 | 2024 | 1363 | 0.190 |
Why?
|
| Knee Joint | 3 | 2022 | 1683 | 0.190 |
Why?
|
| Postoperative Complications | 5 | 2020 | 15824 | 0.190 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 18330 | 0.190 |
Why?
|
| Spinal Fractures | 2 | 2022 | 710 | 0.190 |
Why?
|
| Pravastatin | 3 | 2020 | 393 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4968 | 0.190 |
Why?
|
| Hemiplegia | 2 | 2018 | 137 | 0.190 |
Why?
|
| Retrospective Studies | 28 | 2024 | 81659 | 0.180 |
Why?
|
| Torque | 3 | 2011 | 132 | 0.180 |
Why?
|
| Young Adult | 14 | 2024 | 59980 | 0.180 |
Why?
|
| Stifle | 3 | 2019 | 28 | 0.180 |
Why?
|
| Occipital Bone | 2 | 2020 | 55 | 0.180 |
Why?
|
| Synovial Fluid | 2 | 2024 | 391 | 0.180 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2022 | 327 | 0.180 |
Why?
|
| Hardness Tests | 2 | 2017 | 9 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2270 | 0.170 |
Why?
|
| Water | 2 | 2024 | 1419 | 0.170 |
Why?
|
| Piperidines | 4 | 2020 | 1667 | 0.170 |
Why?
|
| Porphyromonas gingivalis | 1 | 2000 | 165 | 0.170 |
Why?
|
| Contracture | 1 | 2022 | 236 | 0.170 |
Why?
|
| Static Electricity | 2 | 2011 | 258 | 0.170 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2020 | 95 | 0.170 |
Why?
|
| Synchrotrons | 1 | 2019 | 40 | 0.170 |
Why?
|
| Aftercare | 2 | 2023 | 915 | 0.160 |
Why?
|
| Therapeutic Irrigation | 1 | 2020 | 297 | 0.160 |
Why?
|
| Glycerol | 1 | 2020 | 274 | 0.160 |
Why?
|
| Lung Volume Measurements | 2 | 2018 | 381 | 0.160 |
Why?
|
| Standard of Care | 1 | 2023 | 569 | 0.160 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 332 | 0.160 |
Why?
|
| Biocompatible Materials | 5 | 2018 | 1690 | 0.150 |
Why?
|
| Joint Instability | 4 | 2021 | 803 | 0.150 |
Why?
|
| Hip Fractures | 1 | 2007 | 997 | 0.150 |
Why?
|
| Internal Fixators | 2 | 2018 | 183 | 0.150 |
Why?
|
| Joint Diseases | 1 | 2022 | 461 | 0.150 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 293 | 0.150 |
Why?
|
| Length of Stay | 4 | 2022 | 6489 | 0.150 |
Why?
|
| Arthroplasty | 1 | 2020 | 308 | 0.150 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 174 | 0.150 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2010 | 314 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2021 | 1824 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2019 | 2516 | 0.140 |
Why?
|
| Alveolar Bone Loss | 1 | 2000 | 394 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2017 | 5947 | 0.140 |
Why?
|
| Decompression, Surgical | 2 | 2020 | 603 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 2021 | 552 | 0.140 |
Why?
|
| Health Status | 2 | 2016 | 4091 | 0.140 |
Why?
|
| Spondylolisthesis | 1 | 2019 | 173 | 0.140 |
Why?
|
| Treatment Outcome | 18 | 2021 | 65295 | 0.140 |
Why?
|
| Friction | 2 | 2017 | 59 | 0.140 |
Why?
|
| Pyridines | 4 | 2020 | 2890 | 0.140 |
Why?
|
| Pelvis | 2 | 2024 | 736 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2012 | 845 | 0.140 |
Why?
|
| Fractures, Open | 1 | 2018 | 107 | 0.140 |
Why?
|
| Bone Density Conservation Agents | 2 | 2024 | 797 | 0.140 |
Why?
|
| Thumb | 1 | 2018 | 232 | 0.140 |
Why?
|
| Radius Fractures | 2 | 2005 | 515 | 0.130 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 240 | 0.130 |
Why?
|
| Predictive Value of Tests | 5 | 2016 | 15424 | 0.130 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2017 | 116 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2024 | 1043 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 642 | 0.130 |
Why?
|
| Odontoid Process | 1 | 2016 | 46 | 0.130 |
Why?
|
| Traction | 1 | 2016 | 112 | 0.130 |
Why?
|
| Dependent Ambulation | 1 | 2015 | 11 | 0.130 |
Why?
|
| Osteomyelitis | 1 | 2020 | 408 | 0.130 |
Why?
|
| Polyethylene Glycols | 3 | 2010 | 1188 | 0.130 |
Why?
|
| Fibroins | 2 | 2006 | 59 | 0.130 |
Why?
|
| Extracellular Fluid | 1 | 2017 | 165 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2019 | 679 | 0.130 |
Why?
|
| Brain Stem | 2 | 2016 | 858 | 0.120 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39317 | 0.120 |
Why?
|
| Thorax | 2 | 2010 | 556 | 0.120 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 59548 | 0.120 |
Why?
|
| Silk | 2 | 2006 | 93 | 0.120 |
Why?
|
| Critical Pathways | 1 | 2019 | 476 | 0.120 |
Why?
|
| Tissue Engineering | 5 | 2017 | 1861 | 0.120 |
Why?
|
| Hydrogels | 3 | 2016 | 729 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 1027 | 0.120 |
Why?
|
| Vibration | 1 | 2016 | 334 | 0.120 |
Why?
|
| Age Factors | 5 | 2021 | 18401 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2010 | 343 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 2217 | 0.110 |
Why?
|
| Orthopedic Equipment | 1 | 2014 | 22 | 0.110 |
Why?
|
| Off-Label Use | 2 | 2014 | 185 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2020 | 8732 | 0.110 |
Why?
|
| Fibula | 2 | 2015 | 270 | 0.110 |
Why?
|
| Prostheses and Implants | 4 | 2022 | 1275 | 0.110 |
Why?
|
| Uncertainty | 2 | 2022 | 765 | 0.110 |
Why?
|
| Somatosensory Cortex | 1 | 2017 | 506 | 0.110 |
Why?
|
| Calcification, Physiologic | 2 | 2021 | 170 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 640 | 0.110 |
Why?
|
| Age of Onset | 3 | 2015 | 3344 | 0.110 |
Why?
|
| Nephrectomy | 2 | 2009 | 928 | 0.110 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 29 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 697 | 0.110 |
Why?
|
| Motor Skills | 1 | 2016 | 521 | 0.110 |
Why?
|
| Neoplasms | 2 | 2015 | 22350 | 0.100 |
Why?
|
| Aging | 2 | 2020 | 8729 | 0.100 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 71 | 0.100 |
Why?
|
| Patient Discharge | 2 | 2023 | 3467 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2019 | 1271 | 0.100 |
Why?
|
| Diffusion | 1 | 2014 | 810 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1390 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1500 | 0.100 |
Why?
|
| Mentors | 1 | 2017 | 672 | 0.100 |
Why?
|
| Middle Aged | 22 | 2019 | 223233 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2020 | 1811 | 0.100 |
Why?
|
| Tissue Distribution | 3 | 2017 | 2275 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 3370 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2022 | 41718 | 0.100 |
Why?
|
| Collagen | 3 | 2023 | 2636 | 0.100 |
Why?
|
| External Fixators | 2 | 2005 | 99 | 0.090 |
Why?
|
| Fractures, Closed | 2 | 2018 | 88 | 0.090 |
Why?
|
| Diphosphonates | 1 | 2016 | 633 | 0.090 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.090 |
Why?
|
| Adult | 18 | 2019 | 223317 | 0.090 |
Why?
|
| Fingers | 1 | 2014 | 508 | 0.090 |
Why?
|
| Reoperation | 3 | 2019 | 4325 | 0.090 |
Why?
|
| Equipment Design | 2 | 2009 | 3489 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 2 | 2012 | 361 | 0.090 |
Why?
|
| Aged | 21 | 2019 | 171319 | 0.090 |
Why?
|
| Linear Models | 3 | 2015 | 5875 | 0.090 |
Why?
|
| Triiodobenzoic Acids | 1 | 2010 | 124 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 1417 | 0.090 |
Why?
|
| Calcinosis | 1 | 2019 | 1481 | 0.090 |
Why?
|
| Imidazoles | 1 | 2016 | 1169 | 0.090 |
Why?
|
| Risk | 4 | 2020 | 9606 | 0.090 |
Why?
|
| Sheep | 2 | 2024 | 1449 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2015 | 2276 | 0.080 |
Why?
|
| Surface Properties | 3 | 2023 | 1154 | 0.080 |
Why?
|
| Joints | 2 | 2022 | 324 | 0.080 |
Why?
|
| Osteogenesis | 3 | 2006 | 1285 | 0.080 |
Why?
|
| Focus Groups | 1 | 2016 | 1460 | 0.080 |
Why?
|
| Extremities | 1 | 2015 | 870 | 0.080 |
Why?
|
| Risk Factors | 9 | 2020 | 74886 | 0.080 |
Why?
|
| Methylene Blue | 1 | 2009 | 156 | 0.080 |
Why?
|
| Peptides | 3 | 2010 | 4348 | 0.080 |
Why?
|
| Osteochondritis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 630 | 0.080 |
Why?
|
| Range of Motion, Articular | 3 | 2022 | 1597 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2018 | 6260 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2009 | 6331 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 12069 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2022 | 561 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 547 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2016 | 24299 | 0.080 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2015 | 1665 | 0.080 |
Why?
|
| Bone Substitutes | 2 | 2015 | 230 | 0.070 |
Why?
|
| Hospitalization | 3 | 2017 | 10815 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2412 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15925 | 0.070 |
Why?
|
| Organ Size | 2 | 2010 | 2264 | 0.070 |
Why?
|
| Hindlimb | 2 | 2007 | 513 | 0.070 |
Why?
|
| Phenazines | 2 | 2019 | 53 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2018 | 26325 | 0.070 |
Why?
|
| Cartilage | 2 | 2022 | 811 | 0.070 |
Why?
|
| Decamethonium Compounds | 1 | 2006 | 7 | 0.070 |
Why?
|
| Stereotaxic Techniques | 1 | 2009 | 551 | 0.070 |
Why?
|
| Hardness | 2 | 2017 | 34 | 0.070 |
Why?
|
| Carbamates | 1 | 2008 | 191 | 0.070 |
Why?
|
| Fractures, Compression | 1 | 2008 | 132 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1883 | 0.070 |
Why?
|
| Respiration Disorders | 1 | 2010 | 364 | 0.070 |
Why?
|
| Consensus | 3 | 2024 | 3207 | 0.070 |
Why?
|
| Hindlimb Suspension | 1 | 2006 | 77 | 0.070 |
Why?
|
| Species Specificity | 2 | 2021 | 2412 | 0.070 |
Why?
|
| Angioedema | 1 | 2008 | 184 | 0.070 |
Why?
|
| Physical Examination | 2 | 2023 | 1265 | 0.070 |
Why?
|
| Pliability | 1 | 2006 | 57 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2010 | 1092 | 0.060 |
Why?
|
| Biofilms | 1 | 2010 | 641 | 0.060 |
Why?
|
| Epiphyses, Slipped | 1 | 2006 | 87 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7469 | 0.060 |
Why?
|
| Torsion Abnormality | 1 | 2006 | 92 | 0.060 |
Why?
|
| Brain | 3 | 2020 | 27163 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2010 | 1429 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 689 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6513 | 0.060 |
Why?
|
| Ulna | 1 | 2006 | 134 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2010 | 1733 | 0.060 |
Why?
|
| Benzamides | 1 | 2010 | 1376 | 0.060 |
Why?
|
| Infant | 8 | 2021 | 36485 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2006 | 973 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2920 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2010 | 6215 | 0.060 |
Why?
|
| Rats, Nude | 1 | 2024 | 105 | 0.060 |
Why?
|
| Chickens | 1 | 2006 | 843 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3792 | 0.060 |
Why?
|
| Incidence | 3 | 2020 | 21526 | 0.060 |
Why?
|
| Knee Injuries | 3 | 2018 | 495 | 0.060 |
Why?
|
| Platelet-Rich Plasma | 1 | 2007 | 180 | 0.060 |
Why?
|
| Osteomalacia | 1 | 2024 | 60 | 0.060 |
Why?
|
| Casts, Surgical | 1 | 2005 | 184 | 0.060 |
Why?
|
| Goats | 1 | 2024 | 166 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1368 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 1995 | 0.060 |
Why?
|
| Humerus | 1 | 2006 | 273 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22254 | 0.060 |
Why?
|
| Pelvic Bones | 1 | 2006 | 274 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2009 | 1118 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2004 | 529 | 0.050 |
Why?
|
| Pediatrics | 1 | 2018 | 3621 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2016 | 10092 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1233 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2020 | 1430 | 0.050 |
Why?
|
| Disease Management | 3 | 2018 | 2531 | 0.050 |
Why?
|
| Massachusetts | 1 | 2016 | 8890 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3530 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 14098 | 0.050 |
Why?
|
| Phosphorus | 1 | 2023 | 336 | 0.050 |
Why?
|
| Bioreactors | 1 | 2004 | 245 | 0.050 |
Why?
|
| Pain | 2 | 2024 | 5101 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 7435 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 812 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 64 | 0.050 |
Why?
|
| Absorbable Implants | 1 | 2004 | 334 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2024 | 8940 | 0.050 |
Why?
|
| Chondrogenesis | 1 | 2004 | 238 | 0.050 |
Why?
|
| Joint Capsule | 1 | 2022 | 68 | 0.050 |
Why?
|
| Lumbosacral Plexus | 1 | 2022 | 53 | 0.050 |
Why?
|
| Infection Control | 1 | 2009 | 984 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3726 | 0.050 |
Why?
|
| Forecasting | 2 | 2014 | 2936 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2010 | 4052 | 0.050 |
Why?
|
| United States | 4 | 2017 | 72971 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 775 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2006 | 635 | 0.050 |
Why?
|
| Elasticity | 2 | 2018 | 654 | 0.050 |
Why?
|
| Baclofen | 1 | 2022 | 121 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2022 | 317 | 0.050 |
Why?
|
| Single-Blind Method | 2 | 2020 | 1587 | 0.050 |
Why?
|
| Prevotella intermedia | 1 | 2000 | 17 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1515 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 3431 | 0.050 |
Why?
|
| Deep Brain Stimulation | 1 | 2009 | 850 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12536 | 0.050 |
Why?
|
| Logistic Models | 4 | 2019 | 13284 | 0.050 |
Why?
|
| Skull | 1 | 2005 | 819 | 0.050 |
Why?
|
| Stromal Cells | 1 | 2006 | 1335 | 0.040 |
Why?
|
| Inflammation | 1 | 2020 | 10869 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 14766 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2024 | 484 | 0.040 |
Why?
|
| Dental Scaling | 1 | 2000 | 109 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2020 | 101 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2023 | 807 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2010 | 3402 | 0.040 |
Why?
|
| Sialoglycoproteins | 3 | 2006 | 316 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2024 | 356 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 20169 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 2016 | 934 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2024 | 891 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 18063 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3684 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2013 | 10393 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11063 | 0.040 |
Why?
|
| Dental Plaque | 1 | 2000 | 214 | 0.040 |
Why?
|
| Reflex | 1 | 1981 | 375 | 0.040 |
Why?
|
| Speech Disorders | 1 | 2020 | 178 | 0.040 |
Why?
|
| Resuscitation | 2 | 1981 | 681 | 0.040 |
Why?
|
| Osteopontin | 3 | 2006 | 305 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2020 | 139 | 0.040 |
Why?
|
| Wound Healing | 2 | 2008 | 2800 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 3928 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 22361 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3834 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5311 | 0.040 |
Why?
|
| Trapezium Bone | 1 | 2018 | 33 | 0.040 |
Why?
|
| Doxycycline | 1 | 2000 | 348 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2018 | 2429 | 0.040 |
Why?
|
| Stem Cells | 2 | 2022 | 3535 | 0.040 |
Why?
|
| Prognosis | 4 | 2016 | 29963 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2020 | 247 | 0.040 |
Why?
|
| Time Factors | 4 | 2020 | 40154 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4892 | 0.040 |
Why?
|
| Gait | 1 | 2003 | 823 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2020 | 597 | 0.040 |
Why?
|
| Skull Fractures | 3 | 2006 | 202 | 0.040 |
Why?
|
| Swine | 2 | 2024 | 5987 | 0.040 |
Why?
|
| Seizures | 2 | 2020 | 2996 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2018 | 2421 | 0.040 |
Why?
|
| Bone Regeneration | 1 | 2020 | 437 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2019 | 294 | 0.040 |
Why?
|
| Bone Plates | 1 | 2020 | 468 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2001 | 339 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 289 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 284 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 222 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12451 | 0.030 |
Why?
|
| Registries | 2 | 2024 | 8351 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 655 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 21178 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2024 | 1728 | 0.030 |
Why?
|
| Porosity | 2 | 2008 | 346 | 0.030 |
Why?
|
| Bed Rest | 1 | 2016 | 83 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2020 | 768 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2019 | 565 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2018 | 1168 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 81912 | 0.030 |
Why?
|
| Trypsin | 1 | 2017 | 490 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2016 | 70 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 2017 | 303 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5794 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 1936 | 0.030 |
Why?
|
| Touch Perception | 1 | 2017 | 106 | 0.030 |
Why?
|
| Perception | 1 | 2023 | 1205 | 0.030 |
Why?
|
| Macrophages | 1 | 2011 | 5785 | 0.030 |
Why?
|
| Asthma | 1 | 2015 | 6268 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2019 | 536 | 0.030 |
Why?
|
| Computers | 1 | 2018 | 589 | 0.030 |
Why?
|
| Adipose Tissue | 2 | 2024 | 3324 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 504 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 551 | 0.030 |
Why?
|
| Integrin-Binding Sialoprotein | 2 | 2005 | 23 | 0.030 |
Why?
|
| Periodontitis | 1 | 2000 | 576 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 7871 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2020 | 1207 | 0.030 |
Why?
|
| Pressure | 1 | 2018 | 1172 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10455 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2000 | 1148 | 0.030 |
Why?
|
| Hospitals | 2 | 2023 | 3883 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2078 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 2850 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 721 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2020 | 1131 | 0.030 |
Why?
|
| Microelectrodes | 1 | 1996 | 305 | 0.030 |
Why?
|
| Biomimetics | 1 | 2016 | 168 | 0.030 |
Why?
|
| Orbital Fractures | 1 | 1996 | 108 | 0.030 |
Why?
|
| Arthroscopy | 1 | 2021 | 971 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 533 | 0.030 |
Why?
|
| Neurosurgical Procedures | 2 | 2019 | 2075 | 0.030 |
Why?
|
| Calcium | 2 | 2019 | 5792 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2008 | 5098 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 938 | 0.030 |
Why?
|
| Sodium Fluoride | 1 | 2013 | 67 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1308 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 585 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3804 | 0.030 |
Why?
|
| Creatinine | 1 | 2019 | 1916 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1218 | 0.030 |
Why?
|
| Hand | 1 | 2018 | 910 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1201 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2021 | 4026 | 0.030 |
Why?
|
| Motor Activity | 1 | 2003 | 2713 | 0.030 |
Why?
|
| Self Care | 1 | 2018 | 800 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1882 | 0.030 |
Why?
|
| Marketing of Health Services | 1 | 2014 | 151 | 0.030 |
Why?
|
| Autopsy | 1 | 2016 | 1011 | 0.030 |
Why?
|
| Polymerization | 1 | 2013 | 154 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2019 | 1804 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1965 | 0.020 |
Why?
|
| Device Approval | 1 | 2014 | 164 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2020 | 1217 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1331 | 0.020 |
Why?
|
| Health Care Sector | 1 | 2014 | 196 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 4813 | 0.020 |
Why?
|
| Rheology | 1 | 2013 | 346 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 861 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1768 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2014 | 435 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2011 | 12158 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1981 | 1516 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2024 | 3446 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1639 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 1396 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 126 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2013 | 2168 | 0.020 |
Why?
|
| Popliteal Artery | 1 | 1992 | 313 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2010 | 125 | 0.020 |
Why?
|
| Brain Abscess | 1 | 1971 | 122 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 70 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 572 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2015 | 921 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 2118 | 0.020 |
Why?
|
| Ethics, Medical | 2 | 2014 | 785 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 1987 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 360 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2063 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 463 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2212 | 0.020 |
Why?
|
| Vomiting | 1 | 2012 | 655 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 136 | 0.020 |
Why?
|
| Language | 1 | 2018 | 1550 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 877 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2000 | 9660 | 0.020 |
Why?
|
| Informed Consent | 2 | 2014 | 1010 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2015 | 8068 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2616 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2120 | 0.020 |
Why?
|
| Peptide Library | 1 | 2009 | 351 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 150 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 823 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2018 | 3078 | 0.020 |
Why?
|
| Patient Admission | 1 | 2015 | 1364 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9551 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 17097 | 0.020 |
Why?
|
| Psychometrics | 1 | 2017 | 3060 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3618 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2016 | 2252 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9362 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 540 | 0.020 |
Why?
|
| Durapatite | 1 | 2008 | 167 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 311 | 0.020 |
Why?
|
| Iodine | 1 | 2009 | 285 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 665 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10622 | 0.020 |
Why?
|
| Minerals | 1 | 2008 | 279 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 1345 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2012 | 1190 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2006 | 207 | 0.020 |
Why?
|
| Adsorption | 1 | 2006 | 198 | 0.020 |
Why?
|
| Bombyx | 1 | 2006 | 58 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 2658 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6310 | 0.020 |
Why?
|
| Drug Implants | 1 | 2006 | 230 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2428 | 0.020 |
Why?
|
| Body Water | 1 | 2007 | 337 | 0.020 |
Why?
|
| Fibronectins | 1 | 2009 | 722 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 2078 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2811 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 2006 | 99 | 0.020 |
Why?
|
| Diarrhea | 1 | 2012 | 1319 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 817 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7446 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2741 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1556 | 0.020 |
Why?
|
| Joint Prosthesis | 1 | 1987 | 251 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 835 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 156 | 0.010 |
Why?
|
| Body Height | 1 | 2011 | 1565 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 2028 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1743 | 0.010 |
Why?
|
| Materials Testing | 1 | 2008 | 870 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2005 | 416 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 2004 | 73 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4855 | 0.010 |
Why?
|
| Acute Disease | 1 | 2015 | 7236 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8535 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15567 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1389 | 0.010 |
Why?
|
| Cell Differentiation | 3 | 2006 | 11657 | 0.010 |
Why?
|
| Atrophy | 1 | 1988 | 1631 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1987 | 726 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2006 | 1029 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13646 | 0.010 |
Why?
|
| Light | 1 | 2008 | 1358 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2017 | 6597 | 0.010 |
Why?
|
| Weight Gain | 1 | 2012 | 2360 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 363 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16718 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1985 | 395 | 0.010 |
Why?
|
| Protons | 1 | 2007 | 1101 | 0.010 |
Why?
|
| Reflex, Pupillary | 1 | 1981 | 63 | 0.010 |
Why?
|
| Shivering | 1 | 1980 | 11 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7848 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3700 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1988 | 1090 | 0.010 |
Why?
|
| Blinking | 1 | 1981 | 135 | 0.010 |
Why?
|
| Cicatrix | 1 | 2007 | 798 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 10748 | 0.010 |
Why?
|
| Myoclonus | 1 | 1980 | 107 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1666 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6023 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2012 | 3239 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1988 | 6282 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 3618 | 0.010 |
Why?
|
| Cervical Atlas | 1 | 1978 | 22 | 0.010 |
Why?
|
| Microfluidics | 1 | 2004 | 650 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2004 | 18989 | 0.010 |
Why?
|
| Artifacts | 1 | 2007 | 1904 | 0.010 |
Why?
|
| Eye Movements | 1 | 1981 | 510 | 0.010 |
Why?
|
| Mentally Ill Persons | 1 | 1977 | 125 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4473 | 0.010 |
Why?
|
| Maxillary Fractures | 1 | 1996 | 21 | 0.010 |
Why?
|
| Zygomatic Fractures | 1 | 1996 | 35 | 0.010 |
Why?
|
| Ethmoid Bone | 1 | 1996 | 35 | 0.010 |
Why?
|
| Nasal Bone | 1 | 1996 | 58 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 30211 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1988 | 7121 | 0.010 |
Why?
|
| Physicians | 1 | 2013 | 4593 | 0.010 |
Why?
|
| Consciousness | 1 | 1980 | 602 | 0.010 |
Why?
|
| Orbit | 1 | 1996 | 459 | 0.010 |
Why?
|
| Pulse | 1 | 1992 | 217 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7611 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 1977 | 886 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1992 | 591 | 0.010 |
Why?
|
| Unconsciousness | 1 | 1971 | 251 | 0.010 |
Why?
|
| Aneurysm | 1 | 1992 | 343 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1992 | 1104 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 2001 | 3618 | 0.000 |
Why?
|
| Foot | 1 | 1992 | 576 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1992 | 743 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1988 | 6873 | 0.000 |
Why?
|
| Angiography | 1 | 1992 | 1597 | 0.000 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 807 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1971 | 1263 | 0.000 |
Why?
|
| Bone Cements | 1 | 1985 | 327 | 0.000 |
Why?
|
| Dementia | 1 | 1977 | 2741 | 0.000 |
Why?
|
| Paternalism | 1 | 1977 | 49 | 0.000 |
Why?
|
| Minnesota | 1 | 1977 | 339 | 0.000 |
Why?
|
| Social Values | 1 | 1977 | 224 | 0.000 |
Why?
|
| Personal Autonomy | 1 | 1977 | 316 | 0.000 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 1977 | 497 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1985 | 3561 | 0.000 |
Why?
|